2019
DOI: 10.1016/j.anl.2018.09.001
|View full text |Cite
|
Sign up to set email alerts
|

Long-term postoperative control of eosinophilic chronic rhinosinusitis recurrence by inserting a steroid-eluting, sinus-bioabsorbable device reduces the dosage of oral steroid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…Sinonasal topical steroid treatment Sinonasal topical steroid treatment using a bioabsorbable device consisting of oxidised regenerated cellulose (Surgicel Absorbable Haemostat; Johnson and Johnson, Tokyo, Japan) and triamcinolone acetonide (Kenacort, 40 mg/ml vial; Bristol Myers Squibb, Tokyo, Japan) was used, based on previous reports. 16,17 First, cotton swabs impregnated with 4 per cent xylocaine and 5000-fold diluted adrenaline were bilaterally inserted into the surgically opened ethmoid sinuses and olfactory clefts, to shrink the nasal mucosae, for 5-10 minutes. Second, a moderate amount of oxidised regenerated cellulose was inserted bilaterally into the ethmoid sinuses and olfactory clefts.…”
Section: Additional Steroid Treatmentmentioning
confidence: 99%
“…Sinonasal topical steroid treatment Sinonasal topical steroid treatment using a bioabsorbable device consisting of oxidised regenerated cellulose (Surgicel Absorbable Haemostat; Johnson and Johnson, Tokyo, Japan) and triamcinolone acetonide (Kenacort, 40 mg/ml vial; Bristol Myers Squibb, Tokyo, Japan) was used, based on previous reports. 16,17 First, cotton swabs impregnated with 4 per cent xylocaine and 5000-fold diluted adrenaline were bilaterally inserted into the surgically opened ethmoid sinuses and olfactory clefts, to shrink the nasal mucosae, for 5-10 minutes. Second, a moderate amount of oxidised regenerated cellulose was inserted bilaterally into the ethmoid sinuses and olfactory clefts.…”
Section: Additional Steroid Treatmentmentioning
confidence: 99%
“… 3 9 Another feature of eCRSwNP is the efficacy of glucocorticoid therapy. 12 Therefore, glucocorticoid therapy would be helpful to identify these kinds of patients in an early phase, in order to guide overall long-term management. Tissue analysis remains the gold standard for the classification of eCRSwNP and non-eCRSwNP.…”
Section: Introductionmentioning
confidence: 99%